US Bancorp’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7K | Buy |
394
+167
| +74% | +$4.94K | ﹤0.01% | 3369 |
|
|
2025
Q1 | $6.78K | Buy |
227
+65
| +40% | +$1.94K | ﹤0.01% | 3550 |
|
|
2024
Q4 | $4.64K | Hold |
162
| – | – | ﹤0.01% | 3662 |
|
|
2024
Q3 | $6.26K | Hold |
162
| – | – | ﹤0.01% | 3500 |
|
|
2024
Q2 | $5.22K | Buy |
162
+4
| +3% | +$129 | ﹤0.01% | 3485 |
|
|
2024
Q1 | $6.13K | Buy |
+158
| New | +$6.13K | ﹤0.01% | 3465 |
|
|
2023
Q3 | – | Sell |
-75
| Closed | -$1.61K | – | 3977 |
|
|
2023
Q2 | $1.61K | Sell |
75
-9
| -11% | -$193 | ﹤0.01% | 3699 |
|
|
2023
Q1 | $2.02K | Buy |
84
+9
| +12% | +$216 | ﹤0.01% | 3733 |
|
|
2022
Q4 | $1.74K | Hold |
75
| – | – | ﹤0.01% | 3791 |
|
|
2022
Q3 | $1K | Hold |
75
| – | – | ﹤0.01% | 3903 |
|
|
2022
Q2 | $1K | Sell |
75
-318
| -81% | -$4.24K | ﹤0.01% | 3907 |
|
|
2022
Q1 | $8K | Buy |
+393
| New | +$8K | ﹤0.01% | 3422 |
|
|
2021
Q3 | – | Sell |
-31
| Closed | -$1K | – | 4047 |
|
|
2021
Q2 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 3869 |
|
|
2019
Q1 | – | Sell |
-2,449
| Closed | -$42K | – | 3581 |
|
|
2018
Q4 | $42K | Hold |
2,449
| – | – | ﹤0.01% | 2529 |
|
|
2018
Q3 | $36K | Hold |
2,449
| – | – | ﹤0.01% | 2715 |
|
|
2018
Q2 | $58K | Hold |
2,449
| – | – | ﹤0.01% | 2502 |
|
|
2018
Q1 | $63K | Hold |
2,449
| – | – | ﹤0.01% | 2473 |
|
|
2017
Q4 | $45K | Buy |
+2,449
| New | +$45K | ﹤0.01% | 2640 |
|